{"transactions":[{"id":746453,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-08T20:18:09.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2027 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":3.06,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001628280-26-041569","document":"wk-form4_1780949884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000162828026041569/wk-form4_1780949884.xml","form_type":"4"}},{"id":752807,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-03T23:46:34.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":15970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":15970,"derivative":{"exercise_price":0,"exercise_date":"2027-06-01","underlying":"Common Stock","underlying_shares":15970},"source":{"system":"sec-edgar","filing":"0001628280-26-040574","document":"wk-form4_1780530391.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040574/wk-form4_1780530391.xml","form_type":"4"}},{"id":752806,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2026-06-03T23:46:34.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":11069,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11069,"derivative":{"exercise_price":10.52,"exercise_date":"2027-06-01","expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":11069},"source":{"system":"sec-edgar","filing":"0001628280-26-040574","document":"wk-form4_1780530391.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040574/wk-form4_1780530391.xml","form_type":"4"}},{"id":752805,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-03T23:46:34.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":23077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-06-01","underlying":"Common Stock","underlying_shares":23077},"source":{"system":"sec-edgar","filing":"0001628280-26-040574","document":"wk-form4_1780530391.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040574/wk-form4_1780530391.xml","form_type":"4"}},{"id":752804,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T23:46:34.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":23077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":67086,"source":{"system":"sec-edgar","filing":"0001628280-26-040574","document":"wk-form4_1780530391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040574/wk-form4_1780530391.xml","form_type":"4"}},{"id":780192,"issuer":{"id":6565,"kind":"organization","name":"DMC Global Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T22:45:54.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":16937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award is subject to time-based vesting restrictions. The restrictions will lapse on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual stockholder meeting, so long as that meeting is at least 50 weeks after the prior annual meeting."}],"balance_after":65590,"source":{"system":"sec-edgar","filing":"0001769668-26-000002","document":"wk-form4_1778798752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34067/000176966826000002/wk-form4_1778798752.xml","form_type":"4"}},{"id":800242,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:41:19.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":74872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Option vested in full in connection with consummation of the Merger."}],"balance_after":0,"derivative":{"exercise_price":5.96,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":74872},"source":{"system":"sec-edgar","filing":"0001193125-26-182271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182271/ownership.xml","form_type":"4"}},{"id":800241,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:41:19.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.27,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":42467},"source":{"system":"sec-edgar","filing":"0001193125-26-182271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182271/ownership.xml","form_type":"4"}},{"id":800240,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:41:19.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30474,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":12.62,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":30474},"source":{"system":"sec-edgar","filing":"0001193125-26-182271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182271/ownership.xml","form_type":"4"}},{"id":800239,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:41:19.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45423,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.55,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":45423},"source":{"system":"sec-edgar","filing":"0001193125-26-182271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182271/ownership.xml","form_type":"4"}},{"id":800238,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:41:19.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36111,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.71,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":36111},"source":{"system":"sec-edgar","filing":"0001193125-26-182271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182271/ownership.xml","form_type":"4"}},{"id":800237,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-27T20:41:19.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72468,"price":14.5,"value":1050786.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were disposed of in connection with consummation of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. (the \"Merger\"), which included 52,054 shares of Common Stock and 20,414 restricted stock units (which vested in full in connection with consummation of the Merger)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-182271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182271/ownership.xml","form_type":"4"}},{"id":1074892,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:12.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":4.04,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001894562-25-000047","document":"wk-form4_1754440988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000047/wk-form4_1754440988.xml","form_type":"4"}},{"id":1074891,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:12.000Z","date":"2025-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.68,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001894562-25-000047","document":"wk-form4_1754440988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000047/wk-form4_1754440988.xml","form_type":"4"}},{"id":1074890,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:12.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":39062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":39062,"derivative":{"exercise_price":4.04,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":39062},"source":{"system":"sec-edgar","filing":"0001894562-25-000047","document":"wk-form4_1754440988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000047/wk-form4_1754440988.xml","form_type":"4"}},{"id":1074889,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:12.000Z","date":"2025-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":39062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":14.83,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":39062},"source":{"system":"sec-edgar","filing":"0001894562-25-000047","document":"wk-form4_1754440988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000047/wk-form4_1754440988.xml","form_type":"4"}},{"id":1074888,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:12.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":9006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":9006,"derivative":{"exercise_price":4.04,"expiration_date":"2032-10-19","underlying":"Common Stock","underlying_shares":9006},"source":{"system":"sec-edgar","filing":"0001894562-25-000047","document":"wk-form4_1754440988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000047/wk-form4_1754440988.xml","form_type":"4"}},{"id":1074887,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:12.000Z","date":"2025-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2032-10-19","underlying":"Common Stock","underlying_shares":9006},"source":{"system":"sec-edgar","filing":"0001894562-25-000047","document":"wk-form4_1754440988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000047/wk-form4_1754440988.xml","form_type":"4"}},{"id":1074886,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:12.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":13510,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":13510,"derivative":{"exercise_price":4.04,"expiration_date":"2031-11-24","underlying":"Common Stock","underlying_shares":13510},"source":{"system":"sec-edgar","filing":"0001894562-25-000047","document":"wk-form4_1754440988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000047/wk-form4_1754440988.xml","form_type":"4"}},{"id":1074885,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:12.000Z","date":"2025-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13510,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.54,"expiration_date":"2031-11-24","underlying":"Common Stock","underlying_shares":13510},"source":{"system":"sec-edgar","filing":"0001894562-25-000047","document":"wk-form4_1754440988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000047/wk-form4_1754440988.xml","form_type":"4"}},{"id":1120053,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-06-06T20:54:50.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":74872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":74872,"derivative":{"exercise_price":5.96,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":74872},"source":{"system":"sec-edgar","filing":"0000950170-25-083218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017025083218/ownership.xml","form_type":"4"}},{"id":1120052,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:54:50.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":20414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":72468,"source":{"system":"sec-edgar","filing":"0000950170-25-083218","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017025083218/ownership.xml","form_type":"4"}},{"id":1121570,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-05T22:13:22.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2026 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":55000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001628280-25-029771","document":"wk-form4_1749161372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000162828025029771/wk-form4_1749161372.xml","form_type":"4"}},{"id":1125983,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-03T20:08:02.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":23077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":23077,"derivative":{"exercise_price":0,"exercise_date":"2026-06-01","underlying":"Common Stock","underlying_shares":23077},"source":{"system":"sec-edgar","filing":"0001077183-25-000128","document":"wk-form4_1748981269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000128/wk-form4_1748981269.xml","form_type":"4"}},{"id":1125982,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2025-06-03T20:08:02.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":16107,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16107,"derivative":{"exercise_price":7.28,"exercise_date":"2026-06-01","expiration_date":"2035-06-01","underlying":"Common Stock","underlying_shares":16107},"source":{"system":"sec-edgar","filing":"0001077183-25-000128","document":"wk-form4_1748981269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000128/wk-form4_1748981269.xml","form_type":"4"}},{"id":1125981,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-03T20:08:02.000Z","date":"2025-06-01","kind":"exercise","planned":false,"acquired":false,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-06-01","underlying":"Common Stock","underlying_shares":12254},"source":{"system":"sec-edgar","filing":"0001077183-25-000128","document":"wk-form4_1748981269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000128/wk-form4_1748981269.xml","form_type":"4"}},{"id":1125980,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:08:02.000Z","date":"2025-06-01","kind":"exercise","planned":false,"acquired":true,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":44009,"source":{"system":"sec-edgar","filing":"0001077183-25-000128","document":"wk-form4_1748981269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000128/wk-form4_1748981269.xml","form_type":"4"}},{"id":1132435,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-28T20:07:40.000Z","date":"2025-05-27","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":7.6,"value":38000.0,"ownership":{"direct":false,"nature":"M Kelly & B Kelly TTEE Michael and Bonnie Kelly Revocable Trust DTD 05/02/2016"},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001077183-25-000112","document":"wk-form4_1748462854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000112/wk-form4_1748462854.xml","form_type":"4"}},{"id":1148671,"issuer":{"id":6565,"kind":"organization","name":"DMC Global Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T21:11:16.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":17580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award is subject to time-based vesting restrictions. The restrictions will lapse on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual stockholder meeting, so long as the date of the next annual meeting is no earlier than April 29, 2026."}],"balance_after":48653,"source":{"system":"sec-edgar","filing":"0000034067-25-000104","document":"wk-form4_1747343470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34067/000003406725000104/wk-form4_1747343470.xml","form_type":"4"}},{"id":1242291,"issuer":{"id":6565,"kind":"organization","name":"DMC Global Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-27T22:13:07.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":5518,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31073,"source":{"system":"sec-edgar","filing":"0000034067-25-000034","document":"wk-form4_1740694381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34067/000003406725000034/wk-form4_1740694381.xml","form_type":"4"}},{"id":1435185,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-08-13T20:32:09.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":false,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-08-10","underlying":"Common Stock","underlying_shares":11336},"source":{"system":"sec-edgar","filing":"0001077183-24-000131","document":"wk-form4_1723581122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000131/wk-form4_1723581122.xml","form_type":"4"}},{"id":1435184,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:32:09.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":true,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":31755,"source":{"system":"sec-edgar","filing":"0001077183-24-000131","document":"wk-form4_1723581122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000131/wk-form4_1723581122.xml","form_type":"4"}},{"id":1479383,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:59:03.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 12, 2025 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date"}],"balance_after":45000,"derivative":{"exercise_price":7.68,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001894562-24-000038","document":"wk-form4_1718398735.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000038/wk-form4_1718398735.xml","form_type":"4"}},{"id":1487251,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-06-07T23:47:57.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":42467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":42467,"derivative":{"exercise_price":10.27,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":42467},"source":{"system":"sec-edgar","filing":"0000950170-24-071005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024071005/ownership.xml","form_type":"4"}},{"id":1487250,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T23:47:57.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":11847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":52054,"source":{"system":"sec-edgar","filing":"0000950170-24-071005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024071005/ownership.xml","form_type":"4"}},{"id":1493339,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-04T20:09:17.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":12254,"derivative":{"exercise_price":0,"exercise_date":"2025-06-01","underlying":"Common Stock","underlying_shares":12254},"source":{"system":"sec-edgar","filing":"0001077183-24-000094","document":"wk-form4_1717531749.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000094/wk-form4_1717531749.xml","form_type":"4"}},{"id":1493338,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2024-06-04T20:09:17.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":8672,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8672,"derivative":{"exercise_price":13.71,"exercise_date":"2025-06-01","expiration_date":"2034-06-01","underlying":"Common Stock","underlying_shares":8672},"source":{"system":"sec-edgar","filing":"0001077183-24-000094","document":"wk-form4_1717531749.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000094/wk-form4_1717531749.xml","form_type":"4"}},{"id":1516848,"issuer":{"id":6565,"kind":"organization","name":"DMC Global Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T21:25:01.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":9520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that will vest on May 15, 2025."}],"balance_after":25555,"source":{"system":"sec-edgar","filing":"0000034067-24-000085","document":"wk-form4_1715808281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34067/000003406724000085/wk-form4_1715808281.xml","form_type":"4"}},{"id":1809011,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-08-14T21:40:32.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":11336,"derivative":{"exercise_price":0,"exercise_date":"2024-08-10","underlying":"Common Stock","underlying_shares":11336},"source":{"system":"sec-edgar","filing":"0001077183-23-000120","document":"wk-form4_1692049223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000120/wk-form4_1692049223.xml","form_type":"4"}},{"id":1809010,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2023-08-14T21:40:32.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":8353,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8353,"derivative":{"exercise_price":14.82,"exercise_date":"2024-08-10","expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":8353},"source":{"system":"sec-edgar","filing":"0001077183-23-000120","document":"wk-form4_1692049223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000120/wk-form4_1692049223.xml","form_type":"4"}},{"id":1852719,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:48:28.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":39062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 14, 2024 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":39062,"derivative":{"exercise_price":14.83,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":39062},"source":{"system":"sec-edgar","filing":"0001894562-23-000024","document":"wf-form4_168695209562872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456223000024/wf-form4_168695209562872.xml","form_type":"4"}},{"id":1859205,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-06-12T21:40:13.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":30474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":30474,"derivative":{"exercise_price":12.62,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":30474},"source":{"system":"sec-edgar","filing":"0001209191-23-036429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123036429/doc4.xml","form_type":"4"}},{"id":1859204,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T21:40:13.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":8584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":40207,"source":{"system":"sec-edgar","filing":"0001209191-23-036429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123036429/doc4.xml","form_type":"4"}},{"id":1899031,"issuer":{"id":6565,"kind":"organization","name":"DMC Global Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T21:05:14.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":7086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that will vest on May 10, 2024."}],"balance_after":16035,"source":{"system":"sec-edgar","filing":"0000034067-23-000097","document":"wf-form4_168375270101739.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34067/000003406723000097/wf-form4_168375270101739.xml","form_type":"4"}},{"id":2133670,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-21T20:30:39.000Z","date":"2022-10-19","kind":"grant","acquired":true,"shares":9006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest in three equal annual installments beginning on September 13, 2022, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":9006,"derivative":{"exercise_price":17,"expiration_date":"2032-10-19","underlying":"Common Stock","underlying_shares":9006},"source":{"system":"sec-edgar","filing":"0001628280-22-026822","document":"wf-form4_166638421646853.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000162828022026822/wf-form4_166638421646853.xml","form_type":"4"}},{"id":2216685,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T16:09:41.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on June 30, 2023."}],"balance_after":20000,"derivative":{"exercise_price":1.63,"expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-076822","document":"tm2220275-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465922076822/tm2220275-5_4seq1.xml","form_type":"4"}},{"id":2233098,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T00:43:25.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":13882,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13882,"derivative":{"exercise_price":8.1,"exercise_date":"2023-06-10","expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":13882},"source":{"system":"sec-edgar","filing":"0001077183-22-000113","document":"wf-form4_165525379012128.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000113/wf-form4_165525379012128.xml","form_type":"4"}},{"id":2233097,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-15T00:43:25.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":15556,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20419,"source":{"system":"sec-edgar","filing":"0001077183-22-000113","document":"wf-form4_165525379012128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000113/wf-form4_165525379012128.xml","form_type":"4"}},{"id":2236439,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-06-10T20:08:30.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":45423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":45423,"derivative":{"exercise_price":8.55,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":45423},"source":{"system":"sec-edgar","filing":"0001209191-22-035831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122035831/doc4.xml","form_type":"4"}},{"id":2236438,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T20:08:30.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":12671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":31623,"source":{"system":"sec-edgar","filing":"0001209191-22-035831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122035831/doc4.xml","form_type":"4"}},{"id":2274378,"issuer":{"id":6565,"kind":"organization","name":"DMC Global Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T00:43:17.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":5006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that will vest on May 11, 2023."}],"balance_after":8949,"source":{"system":"sec-edgar","filing":"0000034067-22-000076","document":"wf-form4_165240257976220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34067/000003406722000076/wf-form4_165240257976220.xml","form_type":"4"}},{"id":2647062,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T23:07:34.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":22750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 30, 2022, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":22750,"derivative":{"exercise_price":4.88,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":22750},"source":{"system":"sec-edgar","filing":"0001567619-21-012874","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1769668/000156761921012874/doc1.xml","form_type":"4"}},{"id":2647061,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T23:07:34.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":4610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 30, 2021, and which will vest and be settled in common stock on June 30, 2022, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4610,"source":{"system":"sec-edgar","filing":"0001567619-21-012874","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1769668/000156761921012874/doc1.xml","form_type":"4"}},{"id":2670496,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-06-14T23:10:05.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":36111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":36111,"derivative":{"exercise_price":10.71,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":36111},"source":{"system":"sec-edgar","filing":"0001209191-21-040387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121040387/doc4.xml","form_type":"4"}},{"id":2670495,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T23:10:05.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":18952,"source":{"system":"sec-edgar","filing":"0001209191-21-040387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121040387/doc4.xml","form_type":"4"}},{"id":2681542,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T23:59:19.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":3714,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3714,"derivative":{"exercise_price":40.9,"exercise_date":"2022-06-02","expiration_date":"2028-06-02","underlying":"Common Stock","underlying_shares":3714},"source":{"system":"sec-edgar","filing":"0001077183-21-000161","document":"wf-form4_162285111388362.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000161/wf-form4_162285111388362.xml","form_type":"4"}},{"id":2681541,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T23:59:19.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":3081,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4863,"source":{"system":"sec-edgar","filing":"0001077183-21-000161","document":"wf-form4_162285111388362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000161/wf-form4_162285111388362.xml","form_type":"4"}},{"id":2680358,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T20:34:31.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on June 1, 2022."}],"balance_after":9600,"derivative":{"exercise_price":16.61,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001104659-21-077246","document":"tm2118388d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465921077246/tm2118388d2_4seq1.xml","form_type":"4"}},{"id":2713781,"issuer":{"id":6565,"kind":"organization","name":"DMC Global Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T21:04:38.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":1888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that will vest on May 12, 2022."}],"balance_after":3943,"source":{"system":"sec-edgar","filing":"0000034067-21-000077","document":"wf-form4_162102625221833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34067/000003406721000077/wf-form4_162102625221833.xml","form_type":"4"}},{"id":2961108,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-12-02T23:44:58.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":14222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest and become exercisable over a period of four years, with 25% vesting on the first anniversary of the grant with the remainder vesting ratably each month thereafter."}],"balance_after":14222,"derivative":{"exercise_price":22.63,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":14222},"source":{"system":"sec-edgar","filing":"0001209191-20-061286","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120061286/doc4.xml","form_type":"4"}},{"id":2961107,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T23:44:58.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":8837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (RSUs) vest over a period of four years, with 25% vesting on the first anniversary of the grant and 25% on each anniversary thereafter."}],"balance_after":8837,"source":{"system":"sec-edgar","filing":"0001209191-20-061286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120061286/doc4.xml","form_type":"4"}},{"id":3000402,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-23T16:02:49.000Z","date":"2020-10-21","kind":"grant","acquired":true,"shares":5754,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5754,"source":{"system":"sec-edgar","filing":"0001104659-20-117704","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465920117704/a4.xml","form_type":"4"}},{"id":3020506,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true}}],"security":"Stock Option (right to Buy)","published_at":"2020-09-29T21:01:29.000Z","date":"2020-09-28","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on September 28, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":12000,"derivative":{"exercise_price":22.65,"expiration_date":"2030-09-28","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000905148-20-001049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1769668/000090514820001049/form4.xml","form_type":"4"}},{"id":3071601,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-03T22:43:36.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":2223,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2223,"derivative":{"exercise_price":37.53,"exercise_date":"2021-05-28","expiration_date":"2027-05-28","underlying":"Common Stock","underlying_shares":2223},"source":{"system":"sec-edgar","filing":"0001077183-20-000169","document":"wf-form4_159649458478191.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000169/wf-form4_159649458478191.xml","form_type":"4"}},{"id":3071600,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-03T22:43:36.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":1782,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1782,"source":{"system":"sec-edgar","filing":"0001077183-20-000169","document":"wf-form4_159649458478191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000169/wf-form4_159649458478191.xml","form_type":"4"}},{"id":3075445,"issuer":{"id":6565,"kind":"organization","name":"DMC Global Inc."},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-28T12:28:21.000Z","date":"2020-07-24","kind":"grant","acquired":true,"shares":2055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that will vest on July 24, 2021."}],"balance_after":2055,"source":{"system":"sec-edgar","filing":"0000034067-20-000125","document":"wf-form4_159593928828898.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34067/000003406720000125/wf-form4_159593928828898.xml","form_type":"4"}},{"id":3103847,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T16:28:22.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on June 18, 2021."}],"balance_after":9600,"derivative":{"exercise_price":11.45,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001104659-20-075257","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465920075257/a4.xml","form_type":"4"}},{"id":3549818,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":40556,"kind":"person","name":"Kelly Michael Aaron","position":1,"cik":"0001769668","reported_name":"Kelly Michael Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-24T17:33:16.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":19200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on April 17, 2020, with the remainder vesting in 8 equal quarterly installments thereafter."}],"balance_after":19200,"derivative":{"exercise_price":14,"expiration_date":"2029-04-17","underlying":"Common Stock","underlying_shares":19200},"source":{"system":"sec-edgar","filing":"0001104659-19-023452","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465919023452/a4.xml","form_type":"4"}}]}